Drug Safety Research Unit (DSRU) is an independent, non-profit organisation in the United Kingdom, in the field of pharmacology. It is an associate college of the University of Portsmouth,[1] offering postgraduate qualifications in pharmacovigilance.[2]
| Established | 1981 |
|---|---|
| Type | Nonprofit |
| Location | |
Director | Saad Shakir |
Parent organization | University of Portsmouth |
| Website | www |
The unit is based in Southampton,[3] and was established in 1981 by Bill Inman and David Finney.[4] Its director as of July 2021 is Professor Saad Shakir.[3]
It is operated by the Drug Safety Research Trust, a charitable organization registered in England and Wales.[5]
References edit
- ^ "Pharmacy practice research group". University of Portsmouth. Retrieved 22 July 2021.
- ^ Elizabeth Lynn; Deborah Layton; Saad Shakir (1 January 2011). "New postgraduate qualifications in pharmacovigilance from the Drug Safety Research Unit in the UK". Drug Safety. 34 (1): 89–91. doi:10.2165/11586810-000000000-00000. ISSN 0114-5916. PMID 21142274. Wikidata Q51740034.
- ^ a b Liddell, Emily. "Southampton drug safety unit to start study of COVID-19 vaccine". Daily Echo. Retrieved 22 July 2021.
- ^ Finney DJ. From thalidomide to pharmacovigilance: a personal account. Meyler's Side Effects of Drugs Annual 2003, in vol. 26.
- ^ "Drug Safety Research Unit, registered charity no. 327206". Charity Commission for England and Wales.
External links edit
 | This article about an organisation in the United Kingdom is a stub. You can help Wikipedia by expanding it. |